VEA
EBS icon

Virtus ETF Advisers’s Emergent Biosolutions EBS Stock Holding History

Virtus ETF Advisers’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168K Buy
19,990
+490
+3% +$4.1K 0.06% 306
2026
Q1 		$162K Hold
19,500
– – 0.08% 277
2025
Q4 		$241K Buy
+19,500
New +$209K 0.11% 204

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Virtus ETF Advisers's EBS Position: Q2 2026 in Review

Virtus ETF Advisers increased its Emergent Biosolutions (EBS) stake by 2.5% in Q2 2026, buying an estimated $4.1K and bringing the position to 19,990 shares worth $168K. The position accounts for 0.06% of the portfolio, ranked #306.

Virtus ETF Advisers first reported a position in EBS in Q4 2025 and has held it in 3 quarters since. The position peaked at $241K in Q4 2025. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Virtus ETF Advisers held 19,990 shares of Emergent Biosolutions worth $168K as of Q2 2026.
  • Virtus ETF Advisers bought 490 Emergent Biosolutions shares in Q2 2026, an estimated $4.1K.
  • Emergent Biosolutions made up 0.06% of Virtus ETF Advisers's portfolio in Q2 2026, its #306 holding.
  • Virtus ETF Advisers first reported a position in Emergent Biosolutions in Q4 2025 and has held it in 3 quarters since.
  • Virtus ETF Advisers's Emergent Biosolutions position peaked at $241K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.